Evidence map›Paper›PMID 23978468›Full record

ArticleNeurobiology of disease2013

Anti-epileptogenesis: Electrophysiology, diffusion tensor imaging and behavior in a genetic absence model.

Gilles van Luijtelaar, Asht M Mishra, Peter Edelbroek, Daniel Coman, Nikita Frankenmolen, Pauline Schaapsmeerders, Giulio Covolato, Nathan Danielson, Hannah Niermann, Kryzstof Janeczko and 8 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. White matter abnormalities in theFrontiers in molecular neuroscience · 2022
    Article
  9. Neuroimaging in the Epileptic Baboon.Frontiers in veterinary science · 2022
    Review
  10. Review
  11. Review
  12. Review
  13. Frontiers in neurology · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2014
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Gilles van LuijtelaarDonders Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands. Electronic address: g.vanluijtelaar@donders.ru.nl.
Asht M Mishra
Peter Edelbroek
Daniel Coman
Nikita Frankenmolen
Pauline Schaapsmeerders
Giulio Covolato
Nathan Danielson
Hannah Niermann
Kryzstof Janeczko
Anne Kiemeneij
Julija Burinov
Chhitij Bashyal
Madeline Coquillette
Annika Lüttjohann
Fahmeed Hyder
Hal Blumenfeld
Clementina M van Rijn
Radboud University Nijmegen · NLYale University · USJagiellonian University · PLResonance Research (United States) · USStichting Epilepsie Instellingen Nederland · NL

Funding

NeurophysiologicP30NS052519 · NINDS · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2007 to 2017
$6.7M
Energetics of Neuronal Populations by fMRIR01MH067528 · NIMH · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2002 to 2021
$5.9M
Remote effects of focal hippocampal seizures on neocortical functionR01NS066974 · NINDS · YALE UNIVERSITY · PI HAL BLUMENFELD · 2011 to 2026
$5.5M
Preventing spike-wave epileptogenesis: critical periods & neuroimaging biomarkersR01NS049307 · NINDS · YALE UNIVERSITY · PI BLUMENFELD, HAL · 2004 to 2010
$2.3M
NIMH NIH HHS R01 MH067528NIMH NIH HHS R01 MH67528NINDS NIH HHS P30 NS052519NINDS NIH HHS R01 NS049307NINDS NIH HHS R01 NS066974
6 · The paper itself

Abstract

The beneficial effects of chronic and early pharmacological treatment with ethosuximide on epileptogenesis were studied in a genetic absence epilepsy model comorbid for depression. It was also investigated whether there is a critical treatment period and treatment length. Cortical excitability in the form of electrical evoked potentials, but also to cortico-thalamo-cortical network activity (spike-wave discharges, SWD and afterdischarges), white matter changes representing extra cortico-thalamic functions and depressive-like behavior were investigated. WAG/Rij rats received either ethosuximide for 2 months (post natal months 2-3 or 4-5), or ethosuximide for 4 months (2-5) in their drinking water, while control rats drank plain water. EEG measurements were made during treatment, and 6 days and 2 months post treatment. Behavioral test were also done 6 days post treatment. DTI was performed ex vivo post treatment. SWD were suppressed during treatment, and 6 days and 2 months post treatment in the 4 month treated group, as well as the duration of AD elicited by cortical electrical stimulation 6 days post treatment. Increased fractional anisotropy in corpus callosum and internal capsula on DTI was found, an increased P8 evoked potential amplitude and a decreased immobility in the forced swim test. Shorter treatments with ETX had no large effects on any parameter. Chronic ETX has widespread effects not only within but also outside the circuitry in which SWD are initiated and generated, including preventing epileptogenesis and reducing depressive-like symptoms. The treatment of patients before symptom onset might prevent many of the adverse consequences of chronic epilepsy.

Indexed as

Stress, PsychologicalAnimalsAnticonvulsantsBehavior, AnimalBrainDepressionDiffusion Tensor ImagingDisease Models, AnimalElectric StimulationElectroencephalographyEpilepsy, AbsenceEthosuximideEvoked PotentialsMaleRatsRats, Inbred StrainsAnticonvulsantsEthosuximideAfterdischargesAntiepileptogenesisCortical focus theoryDepressionDTIElectrical stimulationEthosuximideSomatosensory cortexWAG/Rij rats

Identifiers

PMID23978468
PMCPMC3952020
OpenAlexW2150439100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.